SELLAS Life Sciences (SLS) Cash from Financing Activities (2019 - 2024)
Historic Cash from Financing Activities for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $19.7 million.
- SELLAS Life Sciences' Cash from Financing Activities rose 3636296.3% to $19.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $50.1 million, marking a year-over-year increase of 15247.26%. This contributed to the annual value of $46.8 million for FY2024, which is 10953.62% up from last year.
- As of Q3 2024, SELLAS Life Sciences' Cash from Financing Activities stood at $19.7 million, which was up 3636296.3% from $414000.0 recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences' Cash from Financing Activities peaked at $26.6 million during Q1 2024, and registered a low of -$29000.0 during Q2 2023.
- Over the past 5 years, SELLAS Life Sciences' median Cash from Financing Activities value was $3.0 million (recorded in 2021), while the average stood at $7.6 million.
- Examining YoY changes over the last 5 years, SELLAS Life Sciences' Cash from Financing Activities showed a top increase of 4012127.66% in 2023 and a maximum decrease of 10012.61% in 2023.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Cash from Financing Activities stood at $23.7 million in 2020, then crashed by 99.79% to $50000.0 in 2021, then skyrocketed by 1758.0% to $929000.0 in 2022, then soared by 264.48% to $3.4 million in 2023, then skyrocketed by 481.51% to $19.7 million in 2024.
- Its Cash from Financing Activities was $19.7 million in Q3 2024, compared to $414000.0 in Q2 2024 and $26.6 million in Q1 2024.